enables chronic electrophysiological evaluation of the ONI. The device consists of two, bipolar cuff electrodes with percutaneous connectors secured to a stainless steel intramedullary rod. Transfemoral amputation was performed in New Zealand white rabbits. The terminal end of the transected sciatic was passed through a proximal corticotomy in the femur, threaded into the medullary cavity and out the end of the bone. The terminal end of the nerve was secured in one cuff electrode and inserted back into the medullary cavity, followed by the intramedullary rod, which was then secured with bone cement. The second cuff electrode was attached to the nerve external to the bone, proximal to the corticotomy. Stimulation (monophasic, cathodal pulses-30µs duration, 100µA-8mA) evoked afferent and efferent compound nerve action potentials (CNAPs) were recorded 3 and 5 weeks post implant with cortical somatosensory evoked potentials (SSEPs) recorded at 5 weeks. Differences in peak CNAP amplitude were investigated with one-way ANOVA.
PURPOSE:
Poor optic nerve regeneration still remains one of the major challenges preventing successful eye transplantation. The purpose of this study was to establish an optic nerve transection model that would allow evaluation of the axonal regeneration of retinal ganglion cells.
METHODS:
Lewis rats were dissected, optic nerves were exposed and transected to create a clean-cut injury. An incision along the superior orbital rim and extending to the lateral temporal area with partial excision of temporalis muscle provided adequate exposure of the optic nerve. The levator palpebrae superioris and superior rectus muscles were transected, the Harderian and lacrimal glands were retracted and preserved. A superior-temporal minimal transverse incision was made on dura mater that provided enough space for optic nerve transection and allowed to retain the integrity of the ophthalmic artery and posterior ciliary artery, which is localized along the posterior nasal side of the optic nerve. Spectral domain optical coherence tomography (SD-OCT), electroretinography (ERG) and confocal scanning laser ophthalmoscopy (cSLO) were used to evaluate morphology, electrical activity and vascular integrity of the retina.
RESULTS: SD-OCT detected progressive atrophy of the retinal nerve fiber layer (RNFL) over the post-operative 12 weeks follow up period. Starting from week 4 there was a noticeable (19.1%) reduction of the RNFL, however, it was not statistically significant (p>0.05) compared to the control side. The difference became statistically significant (p<0.05) at week 6 and by post-operative 12-week RNFL on operated side was reduced by 54.3%. However, the total retinal thickness on the operated side was reduced only by 21.8% (p<0.05). SLO fluorescein and indocyanine green angiography revealed preservation of retinal and choroidal vasculature. Positive peaks were detected on the ERGs of operated eyes in response to flashlight stimulation. However, the amplitudes of the waves were decreased in operated eyes compared to control side.
CONCLUSION:
We developed optic nerve complete transection model that maintains the integrity of the ophthalmic artery and retinal perfusion, which is essential for the preservation of the viability of the retina and evaluation of the optic nerve regeneration.
PURPOSE:
Peripheral nerve injuries can be devastating, leading to permanent functional disabilities. Systemic FK506 administration has been shown to hasten recovery and improve functional outcomes after nerve injury repair. However, high systemic levels of FK506 can result in adverse side-effects. Localized administration of FK506 could provide the neuroregenerative benefits of FK506 while avoiding systemic, off-target side-effects. The purpose of this study is to infestigate the utility of a novel FK506-impregnated nerve wrap in treating peripheral nerve injuries in a previously validated rat infraorbital nerve transection and repair model.
